Esra Erdal

2.0k total citations
43 papers, 1.5k citations indexed

About

Esra Erdal is a scholar working on Molecular Biology, Hepatology and Oncology. According to data from OpenAlex, Esra Erdal has authored 43 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 15 papers in Hepatology and 10 papers in Oncology. Recurrent topics in Esra Erdal's work include Liver physiology and pathology (14 papers), 3D Printing in Biomedical Research (5 papers) and Cancer Cells and Metastasis (4 papers). Esra Erdal is often cited by papers focused on Liver physiology and pathology (14 papers), 3D Printing in Biomedical Research (5 papers) and Cancer Cells and Metastasis (4 papers). Esra Erdal collaborates with scholars based in Türkiye, United States and France. Esra Erdal's co-authors include Neşe Atabey, Zeynep Fırtına Karagonlar, Şerif Şentürk, Peyda Korhan, Soheil Akbari, Mehmet Öztürk, Nuri Öztürk, Sedat Karademır, Özgül Sağol and Günes Özhan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Esra Erdal

42 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esra Erdal Türkiye 22 825 387 345 316 179 43 1.5k
Franziska van Zijl Austria 11 824 1.0× 231 0.6× 604 1.8× 371 1.2× 114 0.6× 13 1.6k
Eva Crosas‐Molist Spain 16 625 0.8× 217 0.6× 293 0.8× 224 0.7× 91 0.5× 22 1.2k
Coral Ho United States 19 1.4k 1.7× 253 0.7× 577 1.7× 592 1.9× 288 1.6× 21 2.1k
Daniela Spano Italy 22 757 0.9× 189 0.5× 404 1.2× 184 0.6× 60 0.3× 37 1.6k
Haeng Ran Seo South Korea 21 615 0.7× 151 0.4× 431 1.2× 286 0.9× 65 0.4× 39 1.2k
Jian Wu China 21 956 1.2× 245 0.6× 474 1.4× 255 0.8× 103 0.6× 91 1.7k
Yoshinobu Toda Japan 26 1.2k 1.4× 182 0.5× 496 1.4× 440 1.4× 293 1.6× 50 2.0k
Heidi L. Kenerson United States 23 801 1.0× 140 0.4× 518 1.5× 202 0.6× 110 0.6× 45 1.7k
Yongjun Tan China 22 1.8k 2.2× 209 0.5× 447 1.3× 303 1.0× 388 2.2× 44 2.2k
Chang Xian Li China 17 451 0.5× 199 0.5× 300 0.9× 266 0.8× 191 1.1× 29 1.2k

Countries citing papers authored by Esra Erdal

Since Specialization
Citations

This map shows the geographic impact of Esra Erdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esra Erdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esra Erdal more than expected).

Fields of papers citing papers by Esra Erdal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esra Erdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esra Erdal. The network helps show where Esra Erdal may publish in the future.

Co-authorship network of co-authors of Esra Erdal

This figure shows the co-authorship network connecting the top 25 collaborators of Esra Erdal. A scholar is included among the top collaborators of Esra Erdal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esra Erdal. Esra Erdal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akbari, Soheil, Nevin Ersoy, Alper Bağrıyanık, et al.. (2025). Generation of Functional Endodermal Hepatic Organoids. Journal of Visualized Experiments.
2.
Erdal, Esra, et al.. (2024). Imaging of Isolated Exosomes by Correlative Microscopy. Journal of Histochemistry & Cytochemistry. 72(3). 149–156. 2 indexed citations
3.
Saglam‐Metiner, Pelin, Soheil Akbari, Bakiye Göker Bağca, et al.. (2023). Spatio-temporal dynamics enhance cellular diversity, neuronal function and further maturation of human cerebral organoids. Communications Biology. 6(1). 173–173. 29 indexed citations
4.
Karagonlar, Zeynep Fırtına, et al.. (2021). Doxorubicin‐induced senescence promotes stemness and tumorigenicity in EpCAM−/CD133− nonstem cell population in hepatocellular carcinoma cell line, HuH‐7. Molecular Oncology. 15(8). 2185–2202. 66 indexed citations
5.
Erdal, Esra, et al.. (2021). Three-Dimensional Cell Culture Models of Hepatocellular Carcinoma — a Review. Journal of Gastrointestinal Cancer. 52(4). 1294–1308. 13 indexed citations
6.
Kuruş, Meltem, et al.. (2021). Transcriptome Dynamics of Human Neuronal Differentiation From iPSC. Frontiers in Cell and Developmental Biology. 9. 727747–727747. 8 indexed citations
7.
Akbari, Soheil, et al.. (2021). LGR5/R-Spo1/Wnt3a axis promotes stemness and aggressive phenotype in hepatoblast-like hepatocellular carcinoma cell lines. Cellular Signalling. 82. 109972–109972. 19 indexed citations
8.
Erdal, Esra, et al.. (2021). Regulation of Wnt Signaling Pathways at the Plasma Membrane and Their Misregulation in Cancer. Frontiers in Cell and Developmental Biology. 9. 631623–631623. 57 indexed citations
9.
Erdal, Esra, et al.. (2019). Antiproliferative activity of (R)-4′-methylklavuzon on hepatocellular carcinoma cells and EpCAM+/CD133+ cancer stem cells via SIRT1 and Exportin-1 (CRM1) inhibition. European Journal of Medicinal Chemistry. 180(2). 224–237. 13 indexed citations
10.
Akbari, Soheil, Nur Arslan, Şerif Şentürk, & Esra Erdal. (2019). Next-Generation Liver Medicine Using Organoid Models. Frontiers in Cell and Developmental Biology. 7. 345–345. 55 indexed citations
11.
Akbari, Soheil, Nevin Ersoy, Onur Başak, et al.. (2019). Robust, Long-Term Culture of Endoderm-Derived Hepatic Organoids for Disease Modeling. Stem Cell Reports. 13(4). 627–641. 107 indexed citations
12.
Atabey, Neşe, et al.. (2017). Role of Albumin in Growth Inhibition in Hepatocellular Carcinoma. Oncology. 93(2). 136–142. 79 indexed citations
13.
Akbari, Soheil, et al.. (2017). Perilipin polymorphisms are risk factors for the development of obesity in adolescents? A case-control study. Lipids in Health and Disease. 16(1). 52–52. 6 indexed citations
14.
Korhan, Peyda, Esra Erdal, & Neşe Atabey. (2014). miR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met. Biochemical and Biophysical Research Communications. 450(4). 1304–1312. 65 indexed citations
15.
Erdal, Esra, Denız Nart, Funda Yılmaz, et al.. (2013). Active form of AKT controls cell proliferation and response to apoptosis in hepatocellular carcinoma. Oncology Reports. 31(2). 573–580. 42 indexed citations
16.
Bozkaya, Giray, Peyda Korhan, Esra Erdal, et al.. (2012). Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis. Molecular Cancer. 11(1). 64–64. 62 indexed citations
18.
Karakülah, Gökhan, et al.. (2012). Early Biventricular Molecular Responses to an Acute Myocardial Infarction. International Journal of Medical Sciences. 9(1). 74–82. 8 indexed citations
19.
Yuzugullu, Haluk, Khemais Benhaj, Nuri Öztürk, et al.. (2009). Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells. Molecular Cancer. 8(1). 90–90. 173 indexed citations
20.
Erdal, Esra, Nuri Öztürk, Tolga Çağatay, Emel Ekşioğlu, & Mehmet Öztürk. (2005). Lithium‐mediated downregulation of PKB/Akt and cyclin E with growth inhibition in hepatocellular carcinoma cells. International Journal of Cancer. 115(6). 903–910. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026